Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
01/2008
01/02/2008CN101095948A Use of ulinastain in the preparing of treating and/or preventing sudden arrest of heart beat tritocerebrum damnification medicine
01/02/2008CN101095899A Chinese herb medicine for treating coronary heart disease
01/02/2008CN101095898A Medicine for treating hypertension
01/02/2008CN101095894A Chinese traditional medicine composition for treating myocardium disease and method of making the same
01/02/2008CN101095885A Chinese traditional medicine for treating myocarditis
01/02/2008CN101095851A Chinese traditional medicine soup composition and method of making the same
01/02/2008CN101095845A Century health preserving magical wine
01/02/2008CN101095823A Heart disease treating medicine
01/02/2008CN101095813A Liposoluble effective extracts from onion white and the extracting method thereof
01/02/2008CN101095812A Polarity effective extracts from onion white and the extracting method thereof
01/02/2008CN101095805A Medicine made by onion and aloe and method for preparing the same
01/02/2008CN101095768A Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
01/02/2008CN101095755A Patch for treating hypertension
01/02/2008CN101095737A Medicine for treating arteriosclerosis hypertension and method for preparing the same
01/02/2008CN101095728A Medicament for treating thromboangitis obliterans and method for producing the same
01/02/2008CN101095727A Hemorrhoid medicine for hui people and vegetarian people
01/02/2008CN101095724A Technics for extracting lotus leaf flavone
01/02/2008CN101095723A Chinese traditional medicine composition for treating ischemic stroke and method for preparing the same
01/02/2008CN101095715A Cardiac and cerebral vascular disease treating medicine composition
01/02/2008CN101095703A Process for preparation of ganoderma lucidum propolis
01/02/2008CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same
01/02/2008CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same
01/02/2008CN101095698A Probiotics and prebiotics for preventing and treating foetid faeces and foetid faeces poisoning syndrome and the composition preparations thereof
01/02/2008CN101095697A Extractive of bdella and/or lumbricus with the molecular weight below 5800 dalton
01/02/2008CN101095683A Chinese traditional medicine for treating hypertension and method for making same
01/02/2008CN101095682A Oral preparations of ivabradine or the medical salt thereof
01/02/2008CN101095680A Preparations containing rosuvastatin calcium and amlodipine and method for preparing the same
01/02/2008CN101095676A Application of sophocarpine and the medicine salt thereof in the preparing of the medicine for treating arrhythmia
01/02/2008CN101095673A Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone as the cytoplasm vacuolated medicine generated by restraining chloro-quinine inducement
01/02/2008CN101095669A Osthole phospholipid complexes and method for preparing the same and application thereof
01/02/2008CN101095663A Nicergoline sustained-release capsules and method for preparing the same
01/02/2008CN101095661A Isosorbide mononitrate orally disintegrating tablets
01/02/2008CN100358899C Platelet activation factor resisting compound
01/02/2008CN100358892C 7-oxo pyridopyrimidines
01/02/2008CN100358891C Pyranones useful as ATM inhibitors
01/02/2008CN100358890C 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors
01/02/2008CN100358888C Novel guanidine mimics as factor Xa inhibitors
01/02/2008CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
01/02/2008CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same
01/02/2008CN100358869C Carbamate caspase inhibitors and uses thereof
01/02/2008CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/02/2008CN100358865C Sulfonamide phenylalkylamine compound, its preparation method and application
01/02/2008CN100358595C Safety shield system for prefilled syringe
01/02/2008CN100358584C Novel compositions magnetic particles covered with gem-bisphosphonate derivatives
01/02/2008CN100358578C Composition for cooperative therapy and method thereof
01/02/2008CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers
01/02/2008CN100358558C Formulation for treating cardiovascular and cerebrovascular disease and its preparation process and quality control method
01/02/2008CN100358550C Chinese traditional medicine for treating bradycardia
01/02/2008CN100358545C Freeze drying powder and injection preparation in use for invigorating pulse-beat, and preparation method
01/02/2008CN100358542C Medicine capable of reducing blood fat and treating anaphylactic rhinitis and preparation method thereof
01/02/2008CN100358539C Quality control method for ginkgo-dipyridamine injection
01/02/2008CN100358530C Medicine prepn for treating cerebral apoplexy and its prepn
01/02/2008CN100358520C Edalavon powder for ampoul injection having good stability and its preparation method
01/02/2008CN100358515C Treatment of neurodegenerative and cardiovascular disorders
01/02/2008CN100358506C Compound musk drip pill and its preparation method
01/02/2008CN100358500C Fleabane and earthworm dripping pill and its preparing method
01/02/2008CN100358495C Prepared licorice granule and its preparation method
01/02/2008CN100358494C Inhalation system
01/01/2008US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation
01/01/2008US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases
01/01/2008US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors
01/01/2008US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
01/01/2008US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
01/01/2008US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis
01/01/2008US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents
01/01/2008US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
01/01/2008US7314870 Compounds, their preparation and use
01/01/2008US7314867 Pharmaceutical composition comprising a retro-iverso isomer peptide
01/01/2008US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility
01/01/2008US7314728 Methods of treating peripheral arterial occlusions
01/01/2008US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells
01/01/2008US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant
01/01/2008US7314484 Methods and devices for treating aneurysms
12/2007
12/27/2007WO2007149874A1 Imidazolidinone kv1.5 potassium channel inhibitors
12/27/2007WO2007149568A2 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide
12/27/2007WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007WO2007149366A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra
12/27/2007WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
12/27/2007WO2007148775A1 Chain amine compound
12/27/2007WO2007148774A1 Cyclic amine compound
12/27/2007WO2007148714A1 Implant using rifamycin derivative
12/27/2007WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient
12/27/2007WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative
12/27/2007WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
12/27/2007WO2007148494A1 Agent for increasing testosterone level
12/27/2007WO2007147889A2 Preparation of telmisartan salts
12/27/2007WO2007147824A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists
12/27/2007WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists
12/27/2007WO2007147713A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/27/2007WO2007147330A1 The application of the bakuchiol compounds
12/27/2007WO2007125315A3 Pharmaceutical compounds
12/27/2007WO2007124254A3 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/27/2007WO2007117559A8 Renin inhibitors
12/27/2007WO2007106708A3 Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril
12/27/2007WO2007106494A3 Methods and compositions for treatment of diastolic heart failure
12/27/2007WO2006016383A3 Natural composition
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007US20070299139 Lyophilisate Comprising N-Diaminomethylene-2-Methyl-4,5-Di(Methylsulfonyl)Benzamide
12/27/2007US20070299138 Treating tumors by administering the octasodium salt of the tetrameric cyclic compound of 4,5-dihydroxynaphthalene-2,7, disulfonic acid linked by methylene bridges; inhibits the secretion of matrix metalloproteinase by endothelial cells
12/27/2007US20070299136 Crystalline and Amorphous Forms of Efaproxiral Sodium